As of December 2022 CRISPR Therapeutics has a market cap of $4.26 Billion. This makes CRISPR Therapeutics the world's 2595th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 1st, 2022 the market cap of CRISPR Therapeutics was reported to be:
|Name||Market cap||Market cap differencediff.||Country|
|$0.15 B||-96.34%||🇺🇸 USA|